be_ixf;ym_202405 d_26; ct_50
NASDAQ:SYM charts & data provided by TradingView

Latest Insights on SYM

Great Stuff 7-17-2019 The Great Amazon Surveillance Sale
by Joseph Hargett July 17, 2019 Great Stuff
In years past, Amazon.com Inc.’s (Nasdaq: AMZN) Prime Day was an event to look forward to. I love online shopping — I never have to leave my house and deal with crowds and uppity cashiers. So, when the biggest online retailer has a massive two-day sale, it’s like Christmas in July. But this year was […]
Somehow, Fed Chairman Jerome Powell’s comments reassured traders. But lower rates are a sign of trouble. And there are reasons to start watching for a Fed panic. Deutsche Bank Is on Deathwatch — Rate Cuts Ahead
by Michael Carr July 15, 2019 Trading Strategies, U.S. Economy, Winning Investor Daily
Somehow, Fed Chairman Jerome Powell’s comments reassured traders. But lower rates are a sign of trouble. And there are reasons to start watching for a Fed panic.
Great Stuff 7-3-2019 Canopy Growth: “Don’t Bring Me Down, Bruce”
by Joseph Hargett July 3, 2019 Great Stuff
Canopy Growth Corp. (NYSE: CGC) has investors running, going out of their minds. Investors are thinking that they’re wasting their time. (Don’t bring me down, no, no, no, no, no.) If you haven’t heard, I’ll tell you once more before I get off the floor. Canopy Growth co-CEO Bruce Linton is out the door. In […]
Great Stuff 6-26-2019 Why Now is Not the Time to Buy Micron Stock
by Joseph Hargett June 26, 2019 Great Stuff
Chips are back, baby! Micron Technology Inc. (Nasdaq: MU) is parting the Red Sea, rallying more than 12% and leading semiconductor stocks to higher ground. Nvidia Corp. (Nasdaq: NVDA) and Advanced Micro Devices Inc. (Nasdaq: AMD) are both up about 5%. Applied Materials Inc. (Nasdaq: AMAT) is up nearly 4%. Even Qualcomm Inc. (Nasdaq: QCOM) […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition
by Joseph Hargett June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

Share This